Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Cancer radio-immunotherapy, integrating external/internal radiation therapy with immuno-
oncology treatments, emerges in the current management of cancer. A growing number of …

Malignant brain tumors, including glioblastoma, represent some of the most difficult to treat
of solid tumors. Nevertheless, recent progress in immunotherapy, across a broad range of …

Ex vivo programming of T cells can be efficacious but is complex and expensive; therefore,
the development of methods to transfect T cells in situ is important. We developed and …

Purpose: Immunomonitoring of chimeric antigen receptor (CAR) T cells relies primarily on
their quantification in the peripheral blood, which inadequately quantifies their …

Immunotherapy is innovating clinical cancer management. Nevertheless, only a small
fraction of patient's benefit from current immunotherapies. To improve clinical management …

Cell therapy has reached significant milestones in various life-threatening diseases,
including cancer. Cell therapy using fluorescent and radiolabeled chimeric antigen receptor …

Immunotherapy is one of the most promising clinical modalities for the treatment of
malignant tumors and has shown excellent therapeutic outcomes in clinical settings …

Imaging of T-cells and their responses during anti-cancer immunotherapy - PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …